Abstract
The analgesic effects of opioids, such as morphine and codeine, in mice are enhanced by oral administration of the cannabinoid Δ9-tetrahydrocannabinol (Δ9-THC). However, isobolographic analysis has never been done to confirm a synergy between Δ9-THC and morphine or codeine via oral routes of administration. To determine the nature of the interaction between these drugs for pain relief and extend previous experimental results, we performed an isobolographic analysis to evaluate for additivity or synergy in the tail-flick test. Fixed-ratio combinations of Δ9-THC with either morphine or codeine were tested for antinociceptive effects. The experimentally derived ED50for each combination was compared with the theoretical additive ED50, using an isobolographic analysis. All of the fixed-ratio combinations tested produced greater antinociception (synergy) than predicted from simple additivity. These findings suggest that the use of a low-dose combination of analgesics is a valid and effective approach for the treatment of pain and necessitates further study.
Footnotes
-
This work was supported by National Institute on Drug Abuse Grants DA-07027, DA-05274, and K02-DA-00186.
-
DOI: 10.1124/jpet.102.045575
- Abbreviations:
- Δ9-THC
- Δ9-tetrahydrocannabinol
- %MPE
- percent maximal possible effect
- CB1
- cannabinoid receptor 1
- Received October 11, 2002.
- Accepted November 12, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|